CytoMed Therapeutics Ltd
GDTC· Nasdaq
Who holds CytoMed Therapeutics Ltd, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Axiom Investment Management LLC | 7K | New | $7.2K | 0.1% | Jul 31, 2026 |
| UBS Group AG | 4.8K | −21.9% | $5K | 0% | Aug 13, 2026 |
| Osaic Holdings, Inc. | 21 | ±0% | $21 | 0% | Aug 14, 2026 |